115 related articles for article (PubMed ID: 10698114)
21. [Determination of recombinant hirudin in urine of rat by spectrophotometric method].
Jiang SY; Jiao J; Lu J; Xu YP; Dou GF
Guang Pu Xue Yu Guang Pu Fen Xi; 2013 May; 33(5):1327-30. PubMed ID: 23905345
[TBL] [Abstract][Full Text] [Related]
22. Immobilized hirudin and hirudin-based peptides used for the purification of recombinant human thrombin prepared from recombinant human prothrombin.
Fischer BE; Mitterer A; Schlokat U; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
Protein Expr Purif; 1996 Sep; 8(2):167-74. PubMed ID: 8812854
[TBL] [Abstract][Full Text] [Related]
23. Specificity determinants for tyrosine protein kinase. A study with recombinant hirudin mutants.
Donella-Deana A; Stone SR; Pinna LA
Eur J Biochem; 1991 Oct; 201(2):501-5. PubMed ID: 1935946
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.
Ofosu FA; Fenton JW; Maraganore J; Blajchman MA; Yang X; Smith L; Anvari N; Buchanan MR; Hirsh J
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic studies with recombinant hirudin in dogs.
Nowak G; Markwardt F; Fink E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):70-4. PubMed ID: 2459035
[TBL] [Abstract][Full Text] [Related]
26. The NMR solution structure of recombinant RGD-hirudin.
Song X; Mo W; Liu X; Zhu L; Yan X; Song H; Dai L
Biochem Biophys Res Commun; 2007 Aug; 360(1):103-8. PubMed ID: 17585879
[TBL] [Abstract][Full Text] [Related]
27. Online preconcentration of recombinant Arg-Gly-Asp-hirudin using dynamic pH junction for analysis in human urine samples by capillary electrophoresis-mass spectrometry.
Su S; Yu Y
J Chromatogr A; 2009 Feb; 1216(9):1490-5. PubMed ID: 19159890
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology of recombinant hirudin.
Nowak G
Semin Thromb Hemost; 2002 Oct; 28(5):415-24. PubMed ID: 12420236
[TBL] [Abstract][Full Text] [Related]
29. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.
Skrzypczak-Jankun E; Carperos VE; Ravichandran KG; Tulinsky A; Westbrook M; Maraganore JM
J Mol Biol; 1991 Oct; 221(4):1379-93. PubMed ID: 1942057
[TBL] [Abstract][Full Text] [Related]
30. Hirudin in disseminated intravascular coagulation.
Nowak G; Markwardt F
Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
[TBL] [Abstract][Full Text] [Related]
31. Transient hydrogen bonds identified on the surface of the NMR solution structure of Hirudin.
Szyperski T; Antuch W; Schick M; Betz A; Stone SR; Wüthrich K
Biochemistry; 1994 Aug; 33(31):9303-10. PubMed ID: 8049231
[TBL] [Abstract][Full Text] [Related]
32. Liquid secondary ion mass spectrometry applied to structural confirmation of enzymically prepared C-terminal-truncated derivatives of recombinant hirudin.
Maftouh M; Ponthus C; Tuong A; Picard C
J Chromatogr; 1991 Jan; 562(1-2):421-34. PubMed ID: 2026708
[TBL] [Abstract][Full Text] [Related]
33. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
De Filippis V; Colombo G; Russo I; Spadari B; Fontana A
Biochemistry; 2002 Nov; 41(46):13556-69. PubMed ID: 12427016
[TBL] [Abstract][Full Text] [Related]
34. State of aggregation of recombinant hirudin in solution under physiological conditions.
Thannhauser TW; Scheraga HA
J Protein Chem; 1996 Nov; 15(8):751-3. PubMed ID: 9008299
[TBL] [Abstract][Full Text] [Related]
35. Liquid chromatography method for determination of bivalirudin in human plasma and urine using automated ortho-phthalaldehyde derivatization and fluorescence detection.
Farthing D; Larus T; Fakhry I; Gehr T; Prats J; Sica D
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 802(2):355-9. PubMed ID: 15018798
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships of recombinant hirudins.
Stürzebecher J; Walsmann P
Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
[TBL] [Abstract][Full Text] [Related]
37. Refined structure of the hirudin-thrombin complex.
Rydel TJ; Tulinsky A; Bode W; Huber R
J Mol Biol; 1991 Sep; 221(2):583-601. PubMed ID: 1920434
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological survey of recombinant hirudin.
Markwardt F; Fink G; Kaiser B; Klöcking HP; Nowak G; Richter M; Stürzebecher J
Pharmazie; 1988 Mar; 43(3):202-7. PubMed ID: 3380865
[TBL] [Abstract][Full Text] [Related]
39. Anti-thrombotic effects of CX-397, a recombinant hirudin analog, in a canine model of coronary artery thrombosis.
Ohyama T; Hori T; Moriike M; Asano T; Hayashi H; Iwade K; Hosoda S
Thromb Haemost; 1998 Feb; 79(2):423-30. PubMed ID: 9493602
[TBL] [Abstract][Full Text] [Related]
40. The structure of a complex of recombinant hirudin and human alpha-thrombin.
Rydel TJ; Ravichandran KG; Tulinsky A; Bode W; Huber R; Roitsch C; Fenton JW
Science; 1990 Jul; 249(4966):277-80. PubMed ID: 2374926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
